Actio Biosciences, Inc.
Benjamin Lewis, PhD, is a Bioinformatics Scientist II at Actio Biosciences, Inc., with a background in bioinformatics, single cell transcriptomics, and functional genomics. Previous experience includes serving as Scientist I at Aspen Neuroscience, Inc., and as a Postdoctoral Fellow at the Salk Institute for Biological Studies, where work focused on CRISPR genome editing and advanced multiomics approaches. Academic qualifications include a Ph.D. in Biology from UC San Diego, a Master of Science in Stem Cell Research from California Polytechnic State University, and a Bachelor of Science with a double major in Biochemistry and Microbiology from the same institution. Early research experience includes roles at Hardy Diagnostics and as an Undergraduate Research Assistant.
Actio Biosciences, Inc.
We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients.